Abstract:The standard non-surgery approach for locally advanced non-small cell lung cancer (NSCLC) isconcurrent chemoradiotherapy. Common chemotherapy regimens include EP, NP, DC and PC. New chemotherapy drugs combination and targeted therapy are still under study. The tolerances of elderly patientsare decliningfor concurrent chemoradiotherapy, butit is not the absolute contraindication. The tolerance for hyperfraction and high dose radiotherapy is well, however, the effectiveness and long-term toxicity need to be further studied and evaluated.

Key words:Lung neoplasms,Radiotherapy,Drug therapy